A Randomized Controlled Study to Evaluate the Safety and Reactogenicity of a Novel rVLP-Based Plant Virus Nanoparticle Adjuvant Combined with Seasonal Trivalent Influenza Vaccine Following Single Immunization in Healthy Adults 18-50 Years of Age.
Vaccines (Basel)
; 8(3)2020 Jul 20.
Article
en En
| MEDLINE
| ID: mdl-32698532
Texto completo:
1
Banco de datos:
MEDLINE
Tipo de estudio:
Clinical_trials
Idioma:
En
Revista:
Vaccines (Basel)
Año:
2020
Tipo del documento:
Article
País de afiliación:
Canadá